Andersons pediatric cardiology 2087

CardiologicalabnormalitiesinNoonan
syndrome:phenotypicdiagnosisand
echocardiographicassessmentin118patients.J
AmCollCardiol.1993;22:1189–1192.
73.MarinoB,DigilioMC,ToscanoA,etal.
Congenitalheartdiseasesinchildrenwith
Noonansindrome:anexpandedcardiac
spectrumwithhighprevalenceof
atrioventricularcanaldefect.JPediatr.
1999;135:703–706.
74.DigilioMC,MarinoB,SarkozyA,etal.The
heartinRas-MAPKpathwaydisorders.Karger:
Basel;2009:109–118.ZenkerM.Noonan
SyndromeandRelatedDisorders.MonogrHum
Genet.Vol17.
75.CalcagniG,LimongelliG,D'AmbrosioA,etal.
Cardiacdefects,morbidityandmortalityin
patientsaffectedbyRASopathies.CARNET
studyresults.IntJCardiol.2017;245:92–98.
76.DigilioMC,MarinoB,GiannottiA,Dallapiccola
B.Exclusionof22q11deletioninNoonan
syndromewithtetralogyoffallot.AmJMed
Genet.1996;62(4):413–414.
77.DigilioMC,MarinoB,PicchioF,etal.Noonan
syndromeandaorticcoarctation.AmJMed
Genet.1998;80(2):160–162.
78.ShachterN,PerloffJK,MulderDG.Aortic


dissectioninnoonan'ssyndrome(46XY
Turner).AmJCardiol.1984;54(3):464–465.

79.PowerPD,LewinMB,HannibalMC,GlassIA.
Aorticrootdilatationisararecomplicationof
Noonansyndrome.PediatrCardiol.
2006;27(4):478–480.
80.CornwallJW,GreenRS,NielsenJC,GelbBD.
FrequencyofaorticdilationinNoonan
syndrome.AmJCardiol.2014;113(2):368–371.
81.PurnellR,WilliamsI,VonOppellU,WoodA.
Giantaneurysmsofthesinusesofvalsalvaand
aorticregurgitationinapatientwithNoonan's
syndrome.EurJCardiothoracSurg.
2005;28(2):346–348.
82.CalcagniG,BabanA,DeLucaE,etal.Coronary
arteryectasiainNoonansyndrome:reportofan
individualwithSOS1mutationandliterature
review.AmJMedGenetA.2016;170(3):665–
669.
83.UcarT,AtalayS,TekinM,TutarE.Bilateral
coronaryarterydilatationandsupravalvular
pulmonarystenosisinachildwithNoonan
syndrome.PediatrCardiol.2005;26(6):848–
850.
84.NarayanswamiS,KitchinerD,SmithA.
SpectrumofvalvarabnormalitiesinNoonan's
syndrome.Apathologicstudy.CardiolYoung.


1994;4:62–66.
85.LimongelliG,PacileoG,MarinoB,etal.
Prevalenceandclinicalsignificanceof

cardiovascularabnormalitiesinpatientswiththe
LEOPARDsyndrome.AmJCardiol.
2007;100:736–741.
86.GelbBD,RobertsAE,TartagliaM.
CardiomyopathiesinNoonansyndromeand
otherRASopathies.ProgPediatrCardiol.
2015;39:13–19.
87.MarinoB,GagliardiMG,DigilioMC,etal.
Noonansyndrome:structuralabnormalitiesof
themitralvalvecausingsubaorticobstruction.
EurJPediatr.1995;154:949–952.
88.DigilioMC,LepriF,DenticiML,etal.
Atrioventricularcanaldefectinpatientswith
RASopathies.EurJHumGenet.2013;21:200–
204.
89.LinAE,AlexanderME,ColanSD,etal.Clinical,
pathological,andmolecularanalysesof
cardiovascularabnormalitiesincostello
syndrome:aRas/MAPKpathwaysyndrome.Am
JMedGenet.2011;155a:486–507.
90.TartagliaM,ZampinoG,GelbBD.Noonan
syndrome:clinicalaspectsandmolecular
pathogenesis.MolSyndromol.2010;1:2–26.
91.DigilioMC,LepriF,BabanA,etal.Rasopathies: